Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats

被引:85
作者
Zhang, YH [1 ]
Raap, DK [1 ]
Garcia, F [1 ]
Serres, F [1 ]
Ma, Q [1 ]
Battaglia, G [1 ]
Van de Kar, LD [1 ]
机构
[1] Loyola Univ, Stritch Sch Med, Dept Pharmacol, Maywood, IL 60153 USA
关键词
serotonin; SSRI; anxiety; defecation; ACTH; oxytocin; prolactin; renin;
D O I
10.1016/S0006-8993(99)02289-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The aim of the present study was to investigate the anxiolytic effects of long-term treatment with fluoxetine in rats. Selective serotonin reuptake inhibitors (SSRIs), such as fluoxetine, are used to treat anxiety and panic disorders, in addition to treating depression. A major concern with SSRIs is a 2-3-week delay in their therapeutic effects. SSRIs share with anxiolytic 5-HT1A agonists the ability to produce desensitization of post-synaptic 5-HT1A receptors. To investigate the anxiolytic effects of fluoxetine, rats were treated for 14 days with fluoxetine (10 mg kg(-1) day(-1), i.p.). The rats were stressed using a conditioned stress procedure and tested one day after the last fluoxetine injection. Fluoxetine decreased stress-induced defecation (by 60%), reversed the stress-induced suppression of exploring behavior (by 59%) and shortened the duration of stress-induced freezing behavior (by 11.5%). However, the stress-induced increase in plasma levels of ACTH, corticosterone, oxytocin, prolactin and renin were not inhibited by fluoxetine treatment. These findings suggest that neuroadaptive changes induced by sustained inhibition of serotonin (5-HT) reuptake, contribute to the mechanism of the anxiolytic effects of fluoxetine. in contrast, the neuroendocrine responses to conditioned stress are not affected by these neuroadaptive changes. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:58 / 66
页数:9
相关论文
共 86 条
[1]   Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas [J].
Adell, A ;
Casanovas, JM ;
Artigas, F .
NEUROPHARMACOLOGY, 1997, 36 (4-5) :735-741
[2]   5-HT AND ANTIDEPRESSANTS - NEW VIEWS FROM MICRODIALYSIS STUDIES [J].
ARTIGAS, F .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (07) :262-262
[3]   Serotonin, anxiety, and stress hormones - Focus on 5-HT receptor subtypes, species and gender differences [J].
Bagdy, G .
STRESS OF LIFE: FROM MOLECULES TO MAN, 1998, 851 :357-363
[4]  
BAGDY G, 1998, METHODS NEUROENDOCRI, P145
[5]   Increased defaecation caused by 5-HT4 receptor activation in the mouse [J].
Banner, SE ;
Smith, MI ;
Bywater, D ;
Gaster, LM ;
Sanger, GJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 308 (02) :181-186
[6]  
BECK CHM, 1995, J NEUROSCI, V15, P709
[7]   MODIFICATION OF 5-HT NEURON PROPERTIES BY SUSTAINED ADMINISTRATION OF THE 5-HT1A AGONIST GEPIRONE - ELECTROPHYSIOLOGICAL STUDIES IN THE RAT-BRAIN [J].
BLIER, P ;
DEMONTIGNY, C .
SYNAPSE, 1987, 1 (05) :470-480
[8]   Forebrain pathways and their behavioural interactions with neuroendocrine and cardiovascular function in the rat [J].
Bohus, B ;
Koolhaas, JM ;
Korte, SM ;
Roozendaal, B ;
Wiersma, A .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1996, 23 (02) :177-182
[9]  
BOYER WF, 1992, J CLIN PSYCHIAT, V53, P3
[10]   ROLE FOR SEROTONIN(3) RECEPTORS IN THE CONTROL OF ADRENOCORTICOTROPIC HORMONE-RELEASE FROM RAT PITUITARY CELL-CULTURES [J].
CALOGERO, AE ;
BAGDY, G ;
BURRELLO, N ;
POLOSA, P ;
DAGATA, R .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1995, 133 (02) :251-254